Boston Scientific Corp

詳細情報 Boston Scientific Corp 企業名

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

企業情報

企業コードBSX

会社名Boston Scientific Corp

上場日May 19, 1992

設立日1979

最高経営責任者「CEO」Mr. Michael F. (Mike) Mahoney

従業員数53000

証券種類Ordinary Share

決算期末May 19

本社所在地300 Boston Scientific Way

都市MARLBOROUGH

証券取引所NYSE Consolidated

国United States of America

郵便番号01752-1234

電話番号15086834000

ウェブサイトhttps://www.bostonscientific.com/en-US/Home.html

企業コードBSX

上場日May 19, 1992

設立日1979

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

31.37K

-13.33%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

4.98K

+71.73%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Ms. Meghan Scanlon

Senior Vice President and President - Urology

--

Mr. David Scott (Dave) Wichmann

Independent Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

31.37K

-13.33%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

4.98K

+71.73%

収益内訳

通貨: USD更新時刻: Sun, Apr 6

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

地域別USD

会社名

収益

比率

United States

10.21B

60.97%

EMEA (Europe, Middle East and Africa)

3.23B

19.28%

Asia Pacific

2.69B

16.04%

Latin America and Canada

624.00M

3.73%

事業別

地域別

事業別USD

会社名

収益

比率

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

株主

更新時刻: Wed, May 14

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

9.05%

Fidelity Management & Research Company LLC

7.94%

BlackRock Institutional Trust Company, N.A.

5.26%

State Street Global Advisors (US)

4.36%

PRIMECAP Management Company

2.47%

Other

70.92%

株主統計

比率

The Vanguard Group, Inc.

9.05%

Fidelity Management & Research Company LLC

7.94%

BlackRock Institutional Trust Company, N.A.

5.26%

State Street Global Advisors (US)

4.36%

PRIMECAP Management Company

2.47%

Other

70.92%

種類

株主統計

比率

Investment Advisor

43.45%

Investment Advisor/Hedge Fund

36.88%

Hedge Fund

3.98%

Pension Fund

2.84%

Research Firm

2.45%

Bank and Trust

1.70%

Sovereign Wealth Fund

1.55%

Private Equity

0.20%

Insurance Company

0.19%

Other

6.76%

機関投資家保有株

更新時刻: Sun, Jan 19

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

2650

1.38B

93.37%

-1.15M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

2022Q4

1993

1.36B

94.66%

-54.91M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

132.25M

8.94%

+1.62M

+1.24%

Dec 31, 2024

Fidelity Management & Research Company LLC

121.20M

8.19%

-2.05M

-1.66%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

76.72M

5.19%

+7.50M

+10.84%

Dec 31, 2024

State Street Global Advisors (US)

63.96M

4.32%

+1.12M

+1.78%

Dec 31, 2024

PRIMECAP Management Company

36.93M

2.5%

-896.83K

-2.37%

Dec 31, 2024

Wellington Management Company, LLP

36.17M

2.45%

+3.34M

+10.19%

Dec 31, 2024

Geode Capital Management, L.L.C.

30.63M

2.07%

+1.04M

+3.52%

Dec 31, 2024

Capital World Investors

27.90M

1.89%

+6.22M

+28.67%

Dec 31, 2024

Managed Account Advisors LLC

17.69M

1.2%

+122.78K

+0.70%

Dec 31, 2024

The Bollard Group, LLC

20.73M

1.4%

-510.32K

-2.40%

Dec 31, 2024

詳細を見る

104.290USD

Boston Scientific Corp

104.290

概要

企業名